<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>JCAD &#187; Cutaneous T-Cell Lymphoma</title>
	<atom:link href="http://www.jcadonline.com/category/areas-of-interest/cutaneous-t-cell-lymphoma/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.jcadonline.com</link>
	<description>The Journal of Clinical and Aesthetic Dermatology (JCAD)</description>
	<lastBuildDate>Thu, 19 Jan 2012 16:38:25 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.1</generator>
		<item>
		<title>Strategies for Treating Cutaneous T-Cell Lymphoma Part 1: Remission</title>
		<link>http://www.jcadonline.com/strategies-for-treating-cutaneous-t-cell-lymphoma-part-1-remission/</link>
		<comments>http://www.jcadonline.com/strategies-for-treating-cutaneous-t-cell-lymphoma-part-1-remission/#comments</comments>
		<pubDate>Fri, 05 Jun 2009 18:45:05 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[06-2009 (June 2009)]]></category>
		<category><![CDATA[Cutaneous T-Cell Lymphoma]]></category>
		<category><![CDATA[Literature Review]]></category>
		<category><![CDATA["jo-ann latkowski" dermatology]]></category>
		<category><![CDATA["jo-ann latkowski" m.d.]]></category>
		<category><![CDATA["peter heald md"]]></category>
		<category><![CDATA["peter heald" and "meeting"]]></category>
		<category><![CDATA["peter heald" yale university school of medicine]]></category>
		<category><![CDATA["topical carmustine" preparation]]></category>
		<category><![CDATA[.latowski]]></category>
		<category><![CDATA[1992 treatment for cleaved cell lymphoma with promius]]></category>
		<category><![CDATA[alternative treatment for ctcl]]></category>
		<category><![CDATA[bexarotene]]></category>
		<category><![CDATA[bone marrow transplant, ctcl]]></category>
		<category><![CDATA[breast implants lymphoma remission]]></category>
		<category><![CDATA[carcinogenic stem cell lymphoma]]></category>
		<category><![CDATA[chemotherapy and photodynamic therapy in treating patients with cutaneous t-cell lymphoma interim results]]></category>
		<category><![CDATA[compounding of topical bcnu]]></category>
		<category><![CDATA[ctcl and puva does it work]]></category>
		<category><![CDATA[ctcl hyperpigmentation]]></category>
		<category><![CDATA[ctcl lymphoma success remissions]]></category>
		<category><![CDATA[ctcl nm]]></category>
		<category><![CDATA[ctcl photos]]></category>
		<category><![CDATA[ctcl puva maintenance therapy]]></category>
		<category><![CDATA[ctcl puva results after weeks]]></category>
		<category><![CDATA[ctcl relapse rate]]></category>
		<category><![CDATA[ctcl remission]]></category>
		<category><![CDATA[ctcl uva]]></category>
		<category><![CDATA[ctcl uvb petrolatum]]></category>
		<category><![CDATA[ctcl vitamin d clinical study therapeutic dose]]></category>
		<category><![CDATA[cutaneous 1a lymphoma]]></category>
		<category><![CDATA[cutaneous lymphoma]]></category>
		<category><![CDATA[cutaneous t cell lymphoma pictures]]></category>
		<category><![CDATA[cutaneous t cell lymphoma stem cell]]></category>
		<category><![CDATA[cutaneous t cell lymphoma, nitric mustard]]></category>
		<category><![CDATA[cutaneous t-cell lymphoma and major surgery]]></category>
		<category><![CDATA[cutaneous t-cell lymphoma in flexural areas]]></category>
		<category><![CDATA[cutaneous t-cell lymphoma pictures case study]]></category>
		<category><![CDATA[cutaneous t-cell lymphoma pictures of face]]></category>
		<category><![CDATA[cutaneous t-cell lymphoma remission]]></category>
		<category><![CDATA[cutaneous t-cell lymphoma skin changes after remission]]></category>
		<category><![CDATA[cutaneous t-cell lymphoma#i=58]]></category>
		<category><![CDATA[cutaneous t-cell lymphomas]]></category>
		<category><![CDATA[cutaneous t-cell lymphomas photos]]></category>
		<category><![CDATA[damage to sweat glands from total skin electron beam therapy]]></category>
		<category><![CDATA[dangers of puva for ctcl 2011]]></category>
		<category><![CDATA[dr. jo-ann latowski]]></category>
		<category><![CDATA[dr. jo-ann latowski, new york]]></category>
		<category><![CDATA[dr. joann latowski]]></category>
		<category><![CDATA[effects of sun on ctcl]]></category>
		<category><![CDATA[electron beam radiation of the eyelid]]></category>
		<category><![CDATA[female latowski]]></category>
		<category><![CDATA[full body skin lymphoma]]></category>
		<category><![CDATA[hair regrowth after tsebt]]></category>
		<category><![CDATA[have there been any new research or study done in 2011 for mycosis fungiodes lyp or new treatments]]></category>
		<category><![CDATA[how do you know if t cell lymphoma is in remission]]></category>
		<category><![CDATA[how does puva work in ctcl patients/]]></category>
		<category><![CDATA[how does uvb work in treating mycosis fungoides]]></category>
		<category><![CDATA[how effective is corticosteroids in treating ctcl]]></category>
		<category><![CDATA[hyperpigmentation]]></category>
		<category><![CDATA[if phototherapy is unsuccessful for the treatment of ctcl what would be the next step]]></category>
		<category><![CDATA[immunosuppression ctcl cancer puva]]></category>
		<category><![CDATA[is there a cure for ctcl stage 1a?]]></category>
		<category><![CDATA[isolated cutaneous t cell lymphoma stage 1 a]]></category>
		<category><![CDATA[jcad 51 part1]]></category>
		<category><![CDATA[jo ann latowski md]]></category>
		<category><![CDATA[jo-ann latkowski, 2011 conference]]></category>
		<category><![CDATA[jo-ann latowski]]></category>
		<category><![CDATA[jo-ann m latkowski]]></category>
		<category><![CDATA[joanne latowski md nyu]]></category>
		<category><![CDATA[joannne latowski md]]></category>
		<category><![CDATA[large areas hyperpigmentation treated]]></category>
		<category><![CDATA[laser burn hypo]]></category>
		<category><![CDATA[laser burn hypopigmentation scarred for life]]></category>
		<category><![CDATA[latowski oncology nyu]]></category>
		<category><![CDATA[latowski#i=3]]></category>
		<category><![CDATA[latowski#i=4]]></category>
		<category><![CDATA[light treatment for mycosis fungoides and electrolyte imbalance]]></category>
		<category><![CDATA[lymphoma part]]></category>
		<category><![CDATA[lymphomas photos]]></category>
		<category><![CDATA[maintenance of mycosis fungoides in remission]]></category>
		<category><![CDATA[moisturizing skin following tsebt]]></category>
		<category><![CDATA[mycosis fungoides hydrocortisone cream]]></category>
		<category><![CDATA[new ctcl treatment]]></category>
		<category><![CDATA[next step after light therapy for ctcl]]></category>
		<category><![CDATA[nyu dermatology and latowski]]></category>
		<category><![CDATA[nyu dermatology latowski]]></category>
		<category><![CDATA[opthalmologist treatment for dry eyes from phototherapy ctcl]]></category>
		<category><![CDATA[parapsoriasis latowski]]></category>
		<category><![CDATA[peter heald and ctcl cure]]></category>
		<category><![CDATA[phototherapy side effects, ctcl]]></category>
		<category><![CDATA[picture of eyelid lymphoma]]></category>
		<category><![CDATA[pictures of advanced state ctcl]]></category>
		<category><![CDATA[pictures of cutaeous t-cell lymphomia]]></category>
		<category><![CDATA[pictures of cutanious lymphoma]]></category>
		<category><![CDATA[pictures of early t cell lymphoma]]></category>
		<category><![CDATA[preparation of topical bcnu]]></category>
		<category><![CDATA[puva therapy following transplant for ctcl]]></category>
		<category><![CDATA[radiation therapy and ctcl]]></category>
		<category><![CDATA[radiation treatment ctcl peter heald]]></category>
		<category><![CDATA[radiotherapy cutaneous t cell lymphoma after complete excision]]></category>
		<category><![CDATA[radiotherapy of cutaneous t cell lymphoma]]></category>
		<category><![CDATA[relapse rate ctcl]]></category>
		<category><![CDATA[remission for cutaneous lymphoma]]></category>
		<category><![CDATA[remission of ctcl]]></category>
		<category><![CDATA[retreatment of patients with bexarotene]]></category>
		<category><![CDATA[return of ctcl 3 years post transplant]]></category>
		<category><![CDATA[role in evaluating bone marow data in ctcl]]></category>
		<category><![CDATA[seminars in oncology saunders ctcl bexarotene]]></category>
		<category><![CDATA[side effects of phototherapy for cutaneous t-cell lymphoma]]></category>
		<category><![CDATA[skin cancer pictures early stages]]></category>
		<category><![CDATA[skin lymphoma full remission after]]></category>
		<category><![CDATA[strategies for treating cutaneous t-cell lymphoma]]></category>
		<category><![CDATA[strategies for treating cutaneous t-cell lymphoma: part 1: remission]]></category>
		<category><![CDATA[subcutaneous t cell lymphoma -filetype:pdf -filetype:ps -filetype:dwf -filetype:kml -filetype:kmz -filetype:xls -filetype:ppt -filetype:doc -filetype:rtf -filetype:swf]]></category>
		<category><![CDATA[sunlight cured t cell lymphoma]]></category>
		<category><![CDATA[surgical procedure for cutaneous t cell lymphoma]]></category>
		<category><![CDATA[t-cell lymphoma hydrocortisone oint]]></category>
		<category><![CDATA[t-cell lymphoma skin cancer nitrogen mustard ointment concentration]]></category>
		<category><![CDATA[therapeutic and aesthetic uses of photodynamic therapy]]></category>
		<category><![CDATA[topical bcnu]]></category>
		<category><![CDATA[topical carmustine (bcnu) in the treatment of mycosis fungoides]]></category>
		<category><![CDATA[total body radiation for cutaneous t cell lymphoma toxicities]]></category>
		<category><![CDATA[total body radiation for treatment of ctcl]]></category>
		<category><![CDATA[total skin electron beam therapy]]></category>
		<category><![CDATA[total skin electron beam therapy university of alabama]]></category>
		<category><![CDATA[total skin electron therapy eye protection]]></category>
		<category><![CDATA[total skin radiation]]></category>
		<category><![CDATA[treating cutaneous t cell lymphoma]]></category>
		<category><![CDATA[treating/cutaneous/lymphpma]]></category>
		<category><![CDATA[treatment for ctcl on eyelid]]></category>
		<category><![CDATA[treatment options following unsuccessful tsebt]]></category>
		<category><![CDATA[tsebt objective response rate]]></category>
		<category><![CDATA[what does it mean when ctcl is successfully cleared up with narrowband uvb light?]]></category>
		<category><![CDATA[what facility is best for treating ctcl]]></category>
		<category><![CDATA[www.subcutaneous t cell lymphoma]]></category>

		<guid isPermaLink="false">http://www.jcadonline.com/?p=1616</guid>
		<description><![CDATA[Jo-Ann Latkowski, MD, New York University School of Medicine, New York, New York; Peter Heald, MD, Yale University School of Medicine, New Haven, Connecticut Abstract In this article, the management of cutaneous T-cell lymphoma will be presented in terms of the strategies that guide treatment. With the strategies and goals in mind, treatment options to [...]]]></description>
		<wfw:commentRss>http://www.jcadonline.com/strategies-for-treating-cutaneous-t-cell-lymphoma-part-1-remission/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

